Comprehensive identification of mutational cancer driver genes across 12 tumor types

被引:11
|
作者
Tamborero, David [1 ]
Gonzalez-Perez, Abel [1 ]
Perez-Llamas, Christian [1 ]
Deu-Pons, Jordi [1 ]
Kandoth, Cyriac [2 ]
Reimand, Jueri [3 ]
Lawrence, Michael S. [4 ,5 ]
Getz, Gad [4 ,5 ]
Bader, Gary D. [3 ]
Ding, Li [2 ,6 ,7 ,8 ]
Lopez-Bigas, Nuria [1 ,9 ]
机构
[1] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain
[2] Washington Univ, Genome Inst, St Louis, MO 63108 USA
[3] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada
[4] MIT, Broad Inst, Cambridge, MA 02142 USA
[5] Harvard Univ, Cambridge, MA 02142 USA
[6] Washington Univ, Dept Genet, Washington, DC USA
[7] Washington Univ, Dept Med, Washington, DC USA
[8] Washington Univ, Siteman Canc Ctr, Washington, DC USA
[9] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
来源
SCIENTIFIC REPORTS | 2013年 / 3卷
基金
美国国家卫生研究院;
关键词
CATALYTIC SUBUNIT; DOWN-REGULATION; ACTIVATION; KINASE; FOXA1; EXPRESSION; P110-BETA; LANDSCAPE; PROTEINS;
D O I
10.1038/srep02650
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
With the ability to fully sequence tumor genomes/exomes, the quest for cancer driver genes can now be undertaken in an unbiased manner. However, obtaining a complete catalog of cancer genes is difficult due to the heterogeneous molecular nature of the disease and the limitations of available computational methods. Here we show that the combination of complementary methods allows identifying a comprehensive and reliable list of cancer driver genes. We provide a list of 291 high-confidence cancer driver genes acting on 3,205 tumors from 12 different cancer types. Among those genes, some have not been previously identified as cancer drivers and 16 have clear preference to sustain mutations in one specific tumor type. The novel driver candidates complement our current picture of the emergence of these diseases. In summary, the catalog of driver genes and the methodology presented here open new avenues to better understand the mechanisms of tumorigenesis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Correlation of tumor mutational burden and predicted functional impact of mutations across cancer types.
    Jia, Jun
    Zhang, Peng
    Liu, Wenjin
    Mu, Shuo
    Chirn, Gung-wei
    Wang, Weifeng
    Wang, Kai
    Dong, Yu-An
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] A model based adjustment for tumor mutational burden across different tumor types
    Wang, M. H.
    Shi, W. W.
    Zhang, P.
    Zhao, S. H.
    Cao, J. Y.
    Chen, M. W.
    Shou, T.
    Hu, J.
    Tang, X. F.
    Song, T. Q.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Signatures of selection for biallelic inactivation in tumor suppressor genes across cancer types
    Zucker, Mark R.
    Perry, Maria A.
    Elkrief, Arielle
    Safonov, Anton
    Thummalapalli, Rohit
    Gould, Samuel I.
    Chakravarty, Debyani
    Brannon, Rose
    Ladanyi, Marc
    Razavi, Pedram
    Donoghue, Mark T.
    Murciano-Goroff, Yonina R.
    Sanchez-Rivera, Francisco J.
    Chen, Yuan
    Shen, Ronglai
    Chandarlapaty, Sarat
    Solit, David B.
    Schultz, Nikolaus
    Berger, Michael F.
    Schoenfeld, Adam J.
    Reznik, Jason Chang Ed
    Bandlamudi, Chaitanya
    CANCER RESEARCH, 2024, 84 (06)
  • [44] Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
    Gandara, David R.
    Agarwal, Neeraj
    Gupta, Shilpa
    Klempner, Samuel J.
    Andrews, Miles C.
    Mahipal, Amit
    Subbiah, Vivek
    Eskander, Ramez N.
    Carbone, David P.
    Riess, Jonathan W.
    Sammons, Sarah
    Snider, Jeremy
    Bouzit, Lilia
    Cho-Phan, Cheryl
    Price, Megan
    Li, Gerald
    Quintanilha, Julia C. F.
    Huang, Richard Sheng Poe
    Ross, Jeffrey S.
    Fabrizio, David
    Oxnard, Geoffrey R.
    Graf, Ryon P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [45] Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing
    Zhou, Chuang
    Chen, Song
    Xu, Fei
    Wei, Jinwang
    Zhou, Xiaoyu
    Wu, Zhiqiang
    Zhao, Longshuan
    Liu, Jun
    Guo, Wenbo
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [46] Tumor mutational burden estimated by whole-exome sequencing across multiple cancer types.
    Xu, Fei
    Wei, Jinwang
    Zhang, Xiaochen
    Dai, Chun
    Wang, Guan
    Xu, Qiang
    CANCER RESEARCH, 2021, 81 (13)
  • [47] Comprehensive identification of bone cancer driver genes by using Li-Fraumeni syndrome iPSCs
    Zhou, Ruoji
    Lin, Yu-Hsuan
    Xu, An
    Jewell, Brittnay E.
    Liu, Ying
    Zhao Ruiying
    Lee, Dung-Fang
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 45 - 45
  • [48] Identification of novel driver genes for colorectal cancer
    Cormier, R.
    Than, B. L. N.
    Zhao, L.
    Scott, P. M.
    Silverstein, K. A. T.
    Zhang, Y.
    Goos, J. A. C. M.
    Fijneman, R. J. A.
    Meijer, G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S560 - S560
  • [49] Mutational state of tumor suppressor genes in oral cancer
    Tanzawa, H
    Uzawa, K
    Wang, XL
    Miyakawa, A
    Shiiba, M
    Watanabe, T
    Miya, T
    Yokoe, H
    Imai, Y
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 499 - 503
  • [50] Comment on 'Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types'
    Bu, Jiawen
    Zhu, Tong
    Zhu, Xudong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)